September 06, 2025 14:30 ET | Source: BridgeBio Pharma, Inc. - 80% of post-surgical hypoparathyroidism participants achieved concomitant blood and…
SAN FRANCISCO, Sept. 06, 2025 (GLOBE NEWSWIRE) -- 23andMe Research Institute, Troper Wojcicki Philanthropies (TWP), and Lifebit today announced the…
After decades of outreach and evidence—never refuted—it is urgent to fund two 3D-CBS devices that could halve cancer deaths, and…
JointCommerce Logo LOS ANGELES, Sept. 06, 2025 (GLOBE NEWSWIRE) -- JointCommerce today announced the launch of the JointCommerce Community, a…
Paris, France, Sept. 05, 2025 (GLOBE NEWSWIRE) -- NetDragon Websoft Holdings Limited (“NetDragon” or the “Company”; Hong Kong Stock Code:…
September 05, 2025 16:37 ET | Source: United Flow Technologies Irving, TX, Sept. 05, 2025 (GLOBE NEWSWIRE) -- United Flow…
New data demonstrate amivantamab combination significantly reduces common EGFR and MET resistance mutations seen with EGFR TKIs1 BEERSE, BELGIUM ,…
TORONTO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a…
September 05, 2025 16:45 ET | Source: Helios Alliance Mobile, Alabama , Sept. 05, 2025 (GLOBE NEWSWIRE) -- Helios Alliance,…
September 05, 2025 18:39 ET | Source: Altai Resources Inc. TORONTO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Altai Resources Inc.…